Omnicell (OMCL) Long-Term Investments (2011 - 2026)
Omnicell's (OMCL) quarterly Long-Term Investments came in at $56.5 million in Q2 2026, up 4.72% year-over-year from $54.0 million in Q2 2025, and down 2.92% quarter-over-quarter from $58.2 million in Q1 2026.
Analysis
Omnicell (OMCL) Long-Term Investments (2011 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Long-Term Investments for 16 consecutive years, with $56.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Long-Term Investments rose 4.72% year-over-year to $56.5 million in Q2 2026; TTM through Jun 2026 was $56.5 million, a 4.72% increase from a year earlier, with the FY2025 full-year figure at $60.7 million, up 15.16% from the prior year.
- Long-Term Investments was $56.5 million for Q2 2026 at Omnicell, down from $58.2 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $60.7 million in Q4 2025 and troughed at $19.1 million in Q1 2022.
- A 5-year average of $44.5 million and a median of $47.1 million in 2024 frame the typical range for Long-Term Investments.
- The widest YoY moves for Long-Term Investments: up 79.02% in 2022, down 10.37% in 2022.
- Over 5 years, Long-Term Investments stood at $32.9 million in 2022, then jumped by 30.46% to $43.0 million in 2023, then grew by 22.79% to $52.7 million in 2024, then advanced by 15.16% to $60.7 million in 2025, then retreated by 6.98% to $56.5 million in 2026.
- The last three Long-Term Investments figures came in at $56.5 million (Q2 2026), $58.2 million (Q1 2026), and $60.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 2.25 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 244.10 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | - |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 56.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.51 Mn |
| Mar 31, 2026 | 58.21 Mn |
| Dec 31, 2025 | 60.74 Mn |
| Sep 30, 2025 | 54.32 Mn |
| Jun 30, 2025 | 53.96 Mn |
| Mar 31, 2025 | 52.53 Mn |
| Dec 31, 2024 | 52.74 Mn |
| Sep 30, 2024 | 50.58 Mn |
| Jun 30, 2024 | 50.30 Mn |
| Mar 31, 2024 | 43.91 Mn |
| Dec 31, 2023 | 42.95 Mn |
| Sep 30, 2023 | 41.63 Mn |
| Jun 30, 2023 | 35.04 Mn |
| Mar 31, 2023 | 32.74 Mn |
| Dec 31, 2022 | 32.92 Mn |
| Sep 30, 2022 | 33.81 Mn |
| Jun 30, 2022 | 29.21 Mn |
| Mar 31, 2022 | 19.05 Mn |
| Dec 31, 2021 | 18.39 Mn |
| Sep 30, 2021 | 19.19 Mn |